Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia 5Lymphoma 4Neuroblastoma 3Lymphoma, Large B-Cell, Diffuse 3Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1Disease 1Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 21Carboplatin 17Etoposide 15Doxorubicin 14Vincristine 13Cisplatin 11Melphalan 10Filgrastim 10Radiotherapy 9Isotretinoin 8Topotecan 7Peripheral Blood Stem Cell Transplantation 6Granulocyte Colony-Stimulating Factor 6dinutuximab 5sargramostim 4etoposide phosphate 4Neoadjuvant Therapy 4Magnetic Resonance Spectroscopy 4Busulfan 4Vindesine 3Thiotepa 3Platinum 3Ifosfamide 3Colony-Stimulating Factors 3Chemotherapy, Adjuvant 3Biopsy 33-Iodobenzylguanidine 31,2-diaminocyclohexaneplatinum II citrate 3liposomal amphotericin B 2fluorodopa F 18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Neuroblastoma × Vindesine × Clear all
NCT03042429 2017-02-06

NB2004-HR

University of Cologne

Phase 3 Completed
360 enrolled
CNS

Neuroblastoma

NCT00002802 2013-12-19

Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Completed
500 enrolled
CNS

Neuroblastoma

NCT00410631 2013-08-07

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Unknown
642 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡